The two programs are being conducted under separate Single-Patient Investigational New Drug (sIND) applications in the United States SAN FRANCISCO, CA / ACCESS Newswire / September 30, 2025 / Jaguar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback